Chief Financial Officer

Senior Vice President CMC Development

Alnylam begins global Phase 3 trial dosing of zilebesiran

Cambridge-based Alnylam Pharmaceuticals pulls TV ad after Trump crackdown on drug industry spots

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,034,085, According to a Recent SEC Filing

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

Business Account Executive, TTR

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking experienced Business Account Executives (BAEs) with specialty sales experience to promote AMVUTTRA™. The BAE will be responsible for identifying healthcare providers, developing plans to increase brand awareness, and achieving territory targets through collaboration with internal and external stakeholders.

Business Account Executive, TTR - Boise

Senior Director Executive Sales Lead - East 

Business Account Executive Rare Disease

Business Account Executive

Business Account Executive - Rare Diseases (PH1 & AHP)

Business Account Executive-Ultra Rare Disease- PH1- Neph/Uro/Ped. Neph/Ped. Ur/AHP-Hem/Oncs/Gastros 

Sign up with Google

Sign in with Google